Efficacy and safety study of atacicept in patients with Systemic Lupus Erythematosus (ADDRESS II)

Update Il y a 4 ans
Reference: EUCTR2013-002773-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary: 1. Evaluate the efficacy of atacicept compared to placebo in reducing SLE disease activity in subjects treated with standard of care (SoC) therapy and to investigate the dose-response relationship.


Inclusion criteria

  • Systemic lupus erythematosus (SLE)